Fri, 26 Jun 2009 15:43:12 -0400 PeerView Press http://www.peerviewpress.com Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker Thought leader perspectives on current clinical advances in medicine. PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. en-us 2008 PeerView Press, 24 West 40th Street, Suite 950, New York, NY, 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/nephrology/podcast_NephrologyCME-CNE-CPE_144.jpg http://www.peerviewpress.com 144 144 Medicine Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Nephrology no PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts in management of CKD-related anemia discuss the inflammatory and other mechanisms that affect hemoglobin variability and hyporesponsiveness, as well as strategies to achieve optimal hemoglobin levels. http://podcast.peerviewpress.com/nephrology/PPVNE05896FCe031.mp3 http://podcast.peerviewpress.com/nephrology/PPVNE05896FCe031.mp3 Fri, 26 Jun 2009 15:22:17 -0400 Science, Medicine no 00:29:30 CKD, chronic kidney disease, anemia, CKD anemia, kidney disease PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/nephrology/PPVNE05896FCCMEinfo.pdf http://podcast.peerviewpress.com/nephrology/PPVNE05986FCCMEinfo.pdf Fri, 26 Jun 2009 15:22:14 -0400 Science, Medicine no 00:00:00 CKD, chronic kidney disease, anemia, CKD anemia, kidney disease PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts discuss recent advances in the management of kidney cancer. Latest data on new and emerging targeted treatment options will be evaluated, treatment options for RCC with sarcomatoid features will be discussed, and an evidence-based treatment algorithm for optimal integration of targeted agents into the current treatment paradigm will be provided. Additionally, research findings from studies aiming to refine the treatment of RCC will be highlighted, including those assessing the potential role of new prognostic models, clinical and genotypic variations that might influence or predict the development of toxicities associated with targeted therapies, and strategies for prevention or overcoming treatment resistance. http://podcast.peerviewpress.com/nephrology/PA05349FCs515.mp3 http://podcast.peerviewpress.com/nephrology/PA05349FCs515.mp3 Mon, 11 May 2009 14:41:39 -0400 Science, Medicine no 00:20:24 renal carcinoma, RCC, bevacizumab, everolimus, sorafenib, sunitnib, TKI, AV-951, VEGF, prognostic models PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/nephrology/PA05349FCCMEinfo.pdf http://podcast.peerviewpress.com/nephrology/PA05349FCCMEinfo.pdf Mon, 11 May 2009 14:41:37 -0400 Science, Medicine no 00:00:00 renal carcinoma, RCC, bevacizumab, everolimus, sorafenib, sunitnib, TKI, AV-951, VEGF, prognostic models PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts in the management of CKD-MBD analyze recent data on detection and management of CKD-MBD from the 41st Annual Meeting & Scientific Exposition of the American Society of Nephrology (Renal Week 2008). http://podcast.peerviewpress.com/nephrology/PA05477FCs539.mp3 http://podcast.peerviewpress.com/nephrology/PA05477FCs539.mp3 Wed, 01 Apr 2009 15:34:03 -0400 Science, Medicine no 00:46:10 chronic kidney disease; mineral bone disorders; renal disease; nephrology PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/nephrology/PA05477FCCMEinfo.pdf http://podcast.peerviewpress.com/nephrology/PA05477FCCMEinfo.pdf Wed, 01 Apr 2009 15:34:01 -0400 Science, Medicine no 00:00:00 chronic kidney disease; mineral bone disorders; renal disease; nephrology PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this program, an expert on kidney cancer provides a concise summary of the key aspects of the biology of renal cell carcinoma (RCC), characteristics of the targeted therapies, and strategies to effectively manage the adverse effects related to these agents. http://podcast.peerviewpress.com/nephrology/PA05122FCn205.mp3 http://podcast.peerviewpress.com/nephrology/PA05122FCn205.mp3 Tue, 10 Mar 2009 16:13:46 -0400 Science, Medicine no 00:18:59 renal cell, targeted, kidney, RCC, mTOR, antiangiogenesis, bevacizumab, sunitinib, everolimus, temsirolimus, sorafenib PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/nephrology/PA05122FCCMEinfo.pdf http://podcast.peerviewpress.com/nephrology/PA05122FCCMEinfo.pdf Tue, 10 Mar 2009 16:13:43 -0400 Science, Medicine no 00:00:00 renal cell, targeted, kidney, RCC, mTOR, antiangiogenesis, bevacizumab, sunitinib, everolimus, temsirolimus, sorafenib PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file or full CME/CE information. In this CME activity, an expert panel discusses the challenges associated with managing anemia in patients with chronic kidney disease, including undertreatment, benefits and risks of therapy, hemoglobin variability, and hyporesponsiveness to erythropoiesis-stimulating agents. http://podcast.peerviewpress.com/nephrology/PA04287FCe013nephrology.mp3 http://podcast.peerviewpress.com/Nephrology/PA04287FCe013nephrology.mp3 Thu, 03 Apr 2008 15:48:03 -0400 Medicine no 00:52:01 Anemia, CERA, chronic kidney disease, darbepoetin, epoetin, Hematide, hyporesponsiveness, hemoglobin variability, ESAs PVI, PeerView Institute for Medical Education Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/nephrology/PA04287FCCMEinfo.pdf http://podcast.peerviewpress.com/Nephrology/PA04287FCCMEinfo.pdf Thu, 03 Apr 2008 15:47:32 -0400 Medicine no 00:00:00 Anemia, CERA, chronic kidney disease, darbepoetin, epoetin, Hematide, hyporesponsiveness, hemoglobin variability, ESAs PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file or full CME/CE information. Disordered mineral metabolism in chronic kidney disease (CKD) can be a challenging problem to manage, with long-reaching consequences to the patient. Several agents are available to address the various sequelae of the condition, but new data-including data on the importance of early treatment of CKD-continue to emerge. This new information may influence the care of patients with CKD and may alter their long-term prognosis. http://podcast.peerviewpress.com/nephrology/PPA04295FCs449.mp3 http://podcast.peerviewpress.com/Nephrology/PA04295FCs449.mp3 Wed, 02 Apr 2008 10:02:16 -0400 Medicine no 00:31:46 Chronic kidney disease, CKD, hyperparathyroidism, vascular calcification, mineral metabolism, calcium, parathyroid hormone, PTH, phosphorus, activated vitamin D PVI, PeerView Institute for Medical Education Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/nephrology/PA04295FCCMEinfo.pdf http://podcast.peerviewpress.com/Nephrology/PA04295FCCMEinfo.pdf Wed, 02 Apr 2008 10:02:04 -0400 Medicine no 00:00:00 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Nephrology